Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-04

Clinical Trial Update: Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia

View source ↗

Summary

Completed clinical trial examining tricuspid regurgitant jet velocity as an independent predictor of mortality in sickle cell disease with pulmonary hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Namita Sood | Conditions: Sickle Cell Anemia, Pulmonary Hypertension | Status: COMPLETED